Abstract
Tumour growth is angiogenesis dependent. Some authors suggest a prognostic role of microvessel count in colorectal cancer. We tested the role of basic fibroblast growth factor (bFGF) and vascular endothelial growth factor (VEGF) in the switch to the angiogenic phenotype in 35 patients with colorectal cancer at different stages of disease. We evaluated the two angiogenic factors, by enzyme-linked immunosorbent assay (ELISA), in tumour, peritumoral mucosa, pathological mesenteric and peripheral blood. We used ten endoscopic intestinal biopsies and ten peripheral blood samples from healthy subjects as control. bFGF was significantly lower in tumour tissues and in peritumoral mucosas than in healthy mucosas, whereas VEGF was up-regulated in tumours but not in peritumoral mucosa. Both angiogenic factors were greatly increased in mesenteric blood. VEGF tumour and serum levels were significantly correlated with the stage of disease. bFGF tumour and serum concentration were not correlated with the stage of disease. The high levels of bFGF in mesenteric blood suggest that this growth factor might be abnormally released from tumour tissue and peritumoral mucosa and could function as an early effector in the switch to the angiogenic phenotype. In contrast, VEGF, whose levels show a significant correlation with the stage of disease, could act in a following step, supporting tumour progression.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 24 print issues and online access
$259.00 per year
only $10.79 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Landriscina, M., Cassano, A., Ratto, C. et al. Quantitative analysis of basic fibroblast growth factor and vascular endothelial growth factor in human colorectal cancer. Br J Cancer 78, 765–770 (1998). https://doi.org/10.1038/bjc.1998.575
Issue Date:
DOI: https://doi.org/10.1038/bjc.1998.575
This article is cited by
-
Minimally invasive colon resection is associated with a persistent increase in plasma PlGF levels following cancer resection
Surgical Endoscopy (2011)
-
Preoperative Serum Placenta Growth Factor Level Is a Prognostic Biomarker in Colorectal Cancer
Diseases of the Colon & Rectum (2009)
-
The intratumoral microvessel density and expression of bFGF and nm23-Hl in colorectal cancer
Pathology & Oncology Research (2006)
-
S100A13, a new marker of angiogenesis in human astrocytic gliomas
Journal of Neuro-Oncology (2006)
-
Arterio-venous gradients of IL-6, plasma and serum VEGF and D-dimers in human cancer
British Journal of Cancer (2002)